Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients

Paula Freitas1, Davide Carvalho, Ana Cristina Santos

  • 1Department of Endocrinology, Hospital de São João and University of Porto Medical School, Porto, Portugal. paula_freitas@sapo.pt

Insights

Hypertension risk in HIV patients with lipodystrophy is debated. This study found hypertension is linked to central fat accumulation, not just lipodystrophy, in HIV-infected adults on antiretroviral therapy.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Endocrinology

Background:

  • Hypertension risk in human immunodeficiency virus (HIV)-infected patients, especially those with lipodystrophy, remains unclear.
  • Combination antiretroviral therapy (cART) is standard for HIV management but can influence body composition and metabolic health.
  • Lipodystrophy, a condition characterized by abnormal fat distribution, is a known complication of cART.

Purpose of the Study:

  • To assess the impact of lipodystrophy on hypertension prevalence in HIV-infected adults on cART.
  • To investigate the association between specific fat distribution patterns and hypertension.
  • To identify body composition factors associated with hypertension in this population.

Main Methods:

  • Cross-sectional study of 368 HIV-infected adults receiving cART.
  • Lipodystrophy assessed clinically and by fat mass ratio (FMR).
  • Body composition evaluated using dual-energy x-ray absorptiometry and computed tomography; blood pressure measured.

Main Results:

  • Overall hypertension prevalence was similar in patients with and without clinically or FMR-defined lipodystrophy.
  • Patients with isolated central fat accumulation and mixed lipodystrophy showed a significantly higher hypertension prevalence.
  • Hypertensive patients had higher total, central, and central/peripheral fat mass ratios.
  • Adjusted analysis confirmed hypertension significantly associated with central/peripheral fat mass ratio (OR, 1.258; 95% CI, 1.008-1.569).

Conclusions:

  • Hypertension is not more prevalent in HIV patients with lipodystrophy overall.
  • Central fat accumulation and mixed lipodystrophy patterns are significantly associated with higher hypertension risk.
  • Central/peripheral fat mass ratio is an independent predictor of hypertension in HIV-infected adults on cART.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors: